OTCMKTS:SBMFF - Sino Biopharmaceutical Stock Price, News & Analysis

+0.14 (+11.76 %)
(As of 08/25/2019 02:22 PM ET)
Today's Range
Now: $1.33
50-Day Range
MA: $1.16
52-Week Range
Now: $1.33
Volume1,300 shs
Average Volume3,304 shs
Market Capitalization$16.81 billion
P/E RatioN/A
Dividend YieldN/A
Sino Biopharmaceutical Limited, researches, develops, manufactures, and sells Chinese medicines and chemical medicines in Hong Kong, Mainland China, and internationally. The company operates in Modernized Chinese Medicines and Chemical Medicines, Investment, and Others segments. Its principal products include hepatitis medicines, such as Runzhong dispersible tablets, Tianqingganmei injections, Tianqingganping enteric capsules, Tianding tablets, Mingzheng capsules, and Ganlixin injections and capsules; and cardio-cerebral medicines comprising Kaishi injections, Yilunping and Tuotuo tablets, Tianqingning injections, and Beraprost Sodium tablets; and oncology medicines consisting of Zhiruo, Saiweijian, Tianqingyitai, and Qingweike injections, as well as Shoufu and Yinishu tablets, and Gelike capsules. Read More…

Industry, Sector and Symbol

Industry Private households
Previous SymbolNASDAQ:SBMFF



Sales & Book Value

Annual Sales$2.04 billion



Outstanding Shares12,637,790,000
Market Cap$16.81 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive SBMFF News and Ratings via Email

Sign-up to receive the latest news and ratings for SBMFF and its competitors with MarketBeat's FREE daily newsletter.

Sino Biopharmaceutical (OTCMKTS:SBMFF) Frequently Asked Questions

What is Sino Biopharmaceutical's stock symbol?

Sino Biopharmaceutical trades on the OTCMKTS under the ticker symbol "SBMFF."

Has Sino Biopharmaceutical been receiving favorable news coverage?

Headlines about SBMFF stock have trended positive this week, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Sino Biopharmaceutical earned a media sentiment score of 2.5 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 6.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the company's share price in the immediate future. View News Stories for Sino Biopharmaceutical.

Who are some of Sino Biopharmaceutical's key competitors?

Who are Sino Biopharmaceutical's key executives?

Sino Biopharmaceutical's management team includes the folowing people:
  • Ms. Y. Y. Tse, Chairlady (Age 26)
  • Mr. Ping Tse, Founder, CEO & Director (Age 67)
  • Ms. Cheung Ling Cheng, Vice Chairlady (Age 55)
  • Mr. Zhoushan Tian, Exec. Director (Age 55)
  • Mr. Shanchun Wang, Exec. Director & Pres of CT Tianqing (Age 51)

How do I buy shares of Sino Biopharmaceutical?

Shares of SBMFF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sino Biopharmaceutical's stock price today?

One share of SBMFF stock can currently be purchased for approximately $1.33.

How big of a company is Sino Biopharmaceutical?

Sino Biopharmaceutical has a market capitalization of $16.81 billion and generates $2.04 billion in revenue each year. Sino Biopharmaceutical employs 21,498 workers across the globe.View Additional Information About Sino Biopharmaceutical.

What is Sino Biopharmaceutical's official website?

The official website for Sino Biopharmaceutical is http://www.sinobiopharm.com/.

How can I contact Sino Biopharmaceutical?

Sino Biopharmaceutical's mailing address is Rm 4109 Office Tower Convention Plaza 1 Harbour Road Wanchai, Hong Kong K3, . The company can be reached via phone at 852-2802-9886 or via email at [email protected]

MarketBeat Community Rating for Sino Biopharmaceutical (OTCMKTS SBMFF)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  67 (Vote Outperform)
Underperform Votes:  91 (Vote Underperform)
Total Votes:  158
MarketBeat's community ratings are surveys of what our community members think about Sino Biopharmaceutical and other stocks. Vote "Outperform" if you believe SBMFF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SBMFF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel